SciELO - Scientific Electronic Library Online

 
vol.48 número4Use of polyethylene glycol to improve the utilisation of leguminous leaf meals in pigs: A review índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google

Compartilhar


South African Journal of Animal Science

versão On-line ISSN 2221-4062
versão impressa ISSN 0375-1589

S. Afr. j. anim. sci. vol.48 no.4 Pretoria  2018

http://dx.doi.org/10.4314/sajas.v48i4.1 

ARTICLES

 

Effects of non-steroidal growth implant and dietary zilpaterol hydrochloride on growth and carcass characteristics of feedlot lambs

 

 

E.C. WebbI, #; J. AllenI; S.D. MorrisII

IDepartment of Animal and Wildlife Science, University of Pretoria. Pretoria, South Africa
IIPrivate Feedlot Consultant & Veterinarian, P.O. Box 53, Strathaven, 2031, South Africa

 

 


ABSTRACT

The effects of steroidal growth implants alone or in combination with β-adrenergic agonist feed additives have not been studied thoroughly in mutton sheep in South African feedlot conditions. This study investigated the effects of a non-steroidal growth implant zeranol (Ralgro®), alone or in combination with zilpaterol hydrochloride (Zilmax®), on growth performance, carcass characteristics, and selected meat quality traits in 160 SA Mutton Merino ram lambs fed in a commercial feedlot. The experimental design consisted of two Ralgro treatment groups x two Zilmax treatments x two Zilmax feeding periods x 20 animals per treatment group. Lambs were randomly allocated to eight treatment groups, of which one half were implanted with Ralgro after arrival, followed by feed supplementation with Zilmax at two Zilmax feeding periods during the finisher phase, compared with negative control treatments (e.g. no Ralgro or Zilmax; Ralgro + no Zilmax; or no Ralgro + Zilmax). All lambs were fed the grower ration traditionally used by the commercial feedlot, which contained 16.89% crude protein (CP) and 2.94 Mcal/kg dry matter (DM). Zilmax was supplemented in the feed at 40 mg per animal per day and fed for 18 days or 25 days, plus three days withdrawal. Lambs that did not receive the Zilmax treatment were fed the basal diet without Zilmax feed supplementation. Ralgro significantly increased average daily gains (ADG) and cold carcass mass (CCM) of lambs. Lambs supplemented with Zilmax during the finisher phase had higher ADG, greater CCM and increased dressing percentage by ca.1.1% compared with those in the control group. Lambs fed Zilmax for 25 days had higher CCM than those fed for 18 days. The duration of the Zilmax treatment also decreased hide weight, fat thickness and shear force values (tenderness). Zilmax increased ADG and CCM in lambs, particularly if combined with Ralgro implants during the growing phase. The results from this study indicate that the combination of Ralgro implants with Zilmax feed supplementation during the finisher phase had additive effects and increased ADG and CCM of feedlot lambs.

Keywords: Growth performance, meat quality, South African Mutton Merino, sheep, Ralgro®, Zilmax®


 

 

Introduction

Zilpaterol hydrochloride (Zilmax®) is a beta-adrenergic agonist (β-agonist) that is used commercially as Zilmax. It is a repartitioning agent and is utilized for its potential to promote growth (Ricks et al., 1984). Zilmax was registered for use in cattle in South Africa in 1995, and is employed commercially in Mexico and the USA (López-Carlos et al., 2011). β-agonists stimulate beta-adrenergic receptors on the cell surface, cause protein synthesis, and inhibit proteolysis, which promotes cell hyperplasia (Mersmann, 1998). The overall response is an increase in growth efficiency, making β-agonists an economical product to use (Courtheyn et al., 2002). The benefits of Zilmax supplementation in lambs are similar to those in beef, with increases in growth performance and carcass characteristics (Avendaño-Reyers et al., 2011; Estrada-Angulo et al., 2008; López-Carlos et al., 2011; López-Carlos et al., 2010). Zilmax is not yet available for use in the local mutton industry, and there are still inconsistencies in the effects, use, and efficacy of β-agonist supplementation and growth performance of feedlot lambs (Estrada-Angulo et al., 2008; López-Carlos et al., 2011; Nourozi et al., 2008).

Lamb and mutton were traditionally produced in extensive systems in South Africa, which did not warrant a fattening phase in the production process (Webb & Erasmus, 2013). However, more producers are looking to an intensive fattening phase, owing to poor growth performance on extensive systems, unpredictable weather, stock theft and a demand for specific carcass grades. Sheep should respond well to β-agonist treatment since they fatten faster and contain considerably more carcass fat than cattle in South Africa (Webb & O'Neill, 2008).

Combining Zilmax and growth-promoting implants is common practice for commercial beef producers. However, it has yet to be investigated in sheep. Research on the combination of steroidal implants and Zilmax in cattle yielded an additive effect (Baxa et al., 2010; Neill et al., 2009). Neill et al. (2009) stated that to realise the full potential of Zilmax, it may be necessary to implant the animal. Zeranol is a non-steroidal growth implant that is manufactured under the name Ralgro® (MSD Animal Health South Africa), which is commonly used in sheep. It is a resorcyclic acid lactone, which is an oestrogen-like compound that is found in corn mould Giberella zeae (Perry et al., 1970; Sharp & Dyer, 1971). The objective of this study was to investigate the effects of a non-steroidal growth implant (Ralgro), alone or in combination with dietary Zilmax supplementation on growth and carcass characteristics of feedlot lambs.

 

Materials and Methods

A completely randomized control study was conducted to evaluate the effects of a non-steroidal exogenous growth implant zeranol (Ralgro), alone or in combination with Zilmax feed additive supplemented during the finishing phase on the growth, carcass, and selected meat quality parameters of mutton sheep fattened in typical feedlot conditions (Table 1). This project was approved by the Animal Ethics Committee of the University of Pretoria in 2015 (#ec030-15).

One hundred and sixty intact SA Mutton Merino lambs of similar age and live mass and from the same breeder were selected at a commercial feedlot near Harrismith, South Africa. Lambs had already undergone the regular feed adaption period used by the feedlot. The initial mass of the lambs was ca. 31.69 kg and all had no permanent incisors. The experimental design consisted of two Ralgro treatment groups x two Zilmax treatments x two Zilmax feeding periods x 20 animals per treatment group (Table 1). A total of 160 lambs of similar phenotype and weight were randomly allocated to one of eight treatment groups. Lambs were identified with ear tags, weighed, and vaccinated on arrival at the feedlot on day 1 (day 1 of trial) with Ovipast Plus® (MSD South Africa), Coglavax® (Ceva South Africa), Virbamax First Drench® (Virbac South Africa) and Prodose Yellow LA® (Virbac South Africa). Lambs randomly allocated to the Ralgro treatment groups were implanted with Ralgro (MSD South Africa) implants in their left ear. After 14 days of adaptation, all lambs received follow-up vaccinations of Multivax-P Plus (MSD South Africa) and Ovipast Plus® (MSD South Africa).

Lambs were randomly allocated to one of four pens consisting of 20 Ralgro implanted and 20 non-implanted animals per pen, totalling 40 lambs per pen. Lambs were identified individually by colour-coded ear tags to differentiate among treatments, with odd numbers indicating the lambs implanted with Ralgro. All lambs were fed the same grower ration traditionally used by the commercial feedlot, which contained 16.89% CP and 2.94 Mcal/kg DM. During the finishing phase, Zilmax was included in the diet by dissolving it in molasses (Zilmol®). Lambs were fed the grower ration for 51 days, followed by 18 days or 25 days of Zilmax inclusion at 40 mg/animal per day in the finisher diets of lambs in the Zilmax treatment groups, and no Zilmax supplementation in the Zilmax control groups. Lambs received water and feed ad libitum. Empty bodyweights of lambs were recorded about 08h00 at the commercial feedlot on day 1 after arrival (day 1), at the end of the growing phase (day 51), and before slaughter (day 72 or day 79). The ADG was calculated and recorded for individual lambs.

Lambs were slaughtered after a total feeding period of 72 days (51 days growing + 18 days Zilmax + 3 days withdrawal) or 79 days (51 days growing + 25 days Zilmax + 3 days withdrawal) at a registered commercial abattoir near Harrismith, South Africa. Hot carcass weight (HCW) was recorded immediately after dressing and removing the hide. The hide was weighed on an electronic scale and recorded. Postmortem inspection was done to document abnormalities. After cooling, the cold carcass weights (CCMs) were recorded and subcutaneous fat thickness was measured at a point over the 13th thoracic vertebra, approximately 5 cm from the medial line (Webb et al., 1994). Carcass pH was recorded at 45 minutes (pH45) and 24 hours (pHu) post mortem by inserting a temperature-compensating meat-type pH electrode into the m. longissimus lumborum approximately 5 cm from the medial line at a point over the 13th thoracic vertebrae. Ten carcasses were randomly selected from each treatment (80 carcasses) and stored at 4 °C. Three-rib cut samples were collected from each carcass according to Webb et al. (1994) and stored in polyethylene bags at -20 °C for dissection and subsequent proximate analysis.

Samples were thawed for 24 hours at 4 °C before analysis. Samples were dissected into muscle, fat and bone to represent an estimate of the total carcass composition (Webb et al., 1994). Samples of the longissimus lumborum muscle were cut, cooked (Babiker et al., 1990), and cooled overnight for subsequent shear force analysis. Four core samples were taken (1.27 cm diameter) parallel with the muscle fibre direction from each sample. Shear force was tested with an Instron apparatus equipped with a Warner-Bratzler shear blade. Samples were placed parallel to the blade (Babiker, et al., 1990; Boleman et al., 2004). Each sample was sheared at a speed of 100 mm/min and shear force values were recorded in Newton (n). The mean shear force of each sample was calculated and recorded.

The effects of Ralgro and Zilmax on growth performance and carcass characteristics of feedlot lambs were analysed using multifactorial analysis of variance (MANOVA) by the general linear model (GLM) procedure of SAS (2011), which included as factors the steroidal implant type, Zilmax treatment, and Zilmax treatment period. Data were recorded in Microsoft Excel. The growth results during the grower phase, finisher phase, entire growth period, and carcass results were analysed statistically by analysis of covariance and general linear regression models, using the initial weight of the lambs as covariate in the model. All these treatment effects and their interactions were tested at a significance level of 95% certainty (P <0.05), and differences between treatment means were assessed by Bonferroni's multiple range test.

 

Results and Discussion

The effects of Ralgro implants and Zilmax supplementation in the feed and the duration of Zilmax feeding of feedlot lambs are presented in Table 2. Ralgro improved the ADG of SA Mutton Merino lambs during the grower phase (P <0.05), but no significant differences were noted during the finisher phase. Treatment with Zilmax improved the ADG (P <0.05) of the lambs during the finisher phase. It is well known that Zilmax increases the growth rate and ADG in cattle (Hope-Jones et al., 2012; Strydom et al., 2011). Similar results were found by Estrada-Angula et al. (2008), López-Carlos et al. (2011), and López-Carlos et al. (2010), who all reported an increase in ADG in sheep supplemented with Zilmax. Lambs implanted with Ralgro also had significantly higher ADG (P <0.01) compared with lambs that were not implanted. These results are consistent with the literature (Nsahlai et al., 2002; Nold et al., 1992). Nold et al. (1992) reported that Ralgro caused higher live weight gains of sheep owing to an increase in efficiency and not feed intake.

To date there have been no combination studies of the effects of Ralgro and Zilmax in sheep. It is well documented that combinations of steroid implants and Zilmax in cattle produce an additive effect (Baxa et al., 2010; Neill et al., 2009). The results of the current study showed that the effects of the combination of Ralgro and Zilmax on ADG were highly significant (P <0.01) and yielded the highest ADG over the entire feeding period and therefore the best growth rates, which agrees with the results in Baxa et al. (2010) and Neill et al. (2009). The highest ADG was recorded for the treatment group that received Ralgro and Zilmax feed supplementation for 25 days (Figure 1), followed by Ralgro and Zilmax feed supplementation for 18 days (Figure 1). From these results it can be seen that the combined use of Ralgro and Zilmax in lambs yields positive results, especially if Zilmax is fed for 25 days.

The duration of the Zilmax treatment did not affect ADG consistently in sheep that were not implanted with Ralgro. This is probably because β-agonists cause a rapid growth response at the onset of treatment, but a plateau is often reached because of desensitization of β-adrenergic receptors (Moody et al., 2000). Growth response over time is not constant with various β-agonists and different species (López-Carlos et al., 2011). It appears that the combination treatment of Ralgro and Zilmax provides a way to enhance the beta-adrenergic agonist effects in lambs, especially at low Zilmax inclusion levels such as those used in this study.

The combination of Ralgro implants and Zilmax feed supplementation increased the cold carcass mass of lambs markedly (P <0.05) compared with those in the other treatment and control groups (Table 3). This result agrees with the findings of Neill et al. (2009) in cows fed concentrate diets implanted with Revelor-200 and supplemented with Zilmax. Baxa et al. (2010) also found that Revalor-S and Zilmax had an additive effect on HCW and dressing percentage in cattle.

The improvements in carcass mass reflect the additive effects between steroidal growth implants and Zilmax, which are consistent with the data on the effects of β-agonists in sheep reported in the literature (Estrada-Angulo et al., 2008; López-Carlos et al., 2011; López-Carlos et al., 2010; Vahedi et al., 2014). The increase in muscle mass is due to the binding of β-agonists to β-receptors on the surface of muscle cells, which modifies biochemical processes, causes a decrease in protein degradation and increases protein synthesis (Mersmann, 1998; Eisemann et al., 1993).

Similarly, Hufstedler et al. (1996) and Hutcheson et al. (1992) reported increased CCM in sheep implanted with Ralgro. However, Nold et al. (1992) argued that Ralgro increased growth rates, but had minimal effects on carcass composition and weight distribution of primal cuts. Salisbury et al. (2007) also found that dressing percentages were unaffected in implanted sheep. The current data indicates a 1% increase in carcass dressing percentage in sheep fed Zilmax (P <0.05; Table 4), while those fed Ralgro alone and those in the control groups were unaffected. This increase in dressing percentage represents an important financial benefit of the use of β-agonists in sheep. No significant differences were observed in subcutaneous fat thickness or carcass pH at 45 minutes or 24 hours post mortem among treatment groups. However, lambs fed Zilmax only had significantly lower hide weights (P <0.05), which may be owing to a reduction of fat in the hide because of the lipolytic effects of Zilmax. Similar results were reported in cattle by Scramlin et al. (2010).

Zilmax had numerically marginal and statistically non-significant effects on the subcutaneous fat thickness of sheep in the present study. In cattle Zilmax improved carcass characteristics, but in sheep the results were less consistent (López-Carlos et al., 2010). Some researchers reported a decrease in subcutaneous fat thickness in sheep supplemented with Zilmax (López-Carlos et al., 2010; Vahedi et al., 2014), while others found no difference (Avendaño-Reyers et al., 2011; Estrada-Angulo et al., 2008).

The duration of the Zilmax treatment affected (P <0.05) most carcass parameters, including CCM, dressing percentage, subcutaneous fat thickness, hide weights and ultimate pH values. Although